Home › Funds › Freestone Capital Holdings, LLC › ABUS
Freestone Capital Holdings, LLC position in ABUS
ARBUTUS BIOPHARMA CORP · Health Care
Latest position (Q2 2026)442.50K sh
Reported value held$2.12M
Portfolio Weight0.07%
First reportedQ2 2026
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 442.50K | $2.12M | New |
Other funds holding ABUS
- CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 891.17K sh · $185.66M · Q2 2026
- Morgan Stanley 17.70M sh · $84.95M · Q2 2026
- Whitefort Capital Management, LP 15.79M sh · $75.81M · Q2 2026
- BlackRock Inc 13.77M sh · $66.08M · Q2 2026
- Vanguard Group 9.24M sh · $44.46M · Q4 2025
- Two Seas Capital LP 8.14M sh · $38.93M · Q3 2026
- Rubric Capital Management LP 7.53M sh · $36.16M · Q2 2026
- VANGUARD CAPITAL MANAGEMENT LLC 7.01M sh · $33.65M · Q2 2026
- Geode Capital Management 4.12M sh · $19.77M · Q2 2026
- GEODE CAPITAL MANAGEMENT, LLC 4.12M sh · $19.77M · Q2 2026
- Goldman Sachs Group 3.51M sh · $16.83M · Q2 2026
- Bank of America Corp 2.65M sh · $12.70M · Q2 2026